ValueSet-2.16.840.1.113883.3.464.1003.110.12.1084

Sourceus.nlm.vsac#0.11.0:null (v4.0.1)
resourceTypeValueSet
id2.16.840.1.113883.3.464.1003.110.12.1084
canonicalhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084
version20190315
statusactive
publisherNCQA PHEMUR
nameHibVaccine3DoseScheduleAdministered
titleHib Vaccine (3 dose schedule) Administered
date2022-03-03T18:46:01-05:00
experimentalfalse
Usages(none)

This value set contains 8 concepts

Code System Display
   127787002 http://snomed.info/sct Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)
   170343007 http://snomed.info/sct Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)
   170344001 http://snomed.info/sct Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)
   170345000 http://snomed.info/sct Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)
   170346004 http://snomed.info/sct Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)
  90647 http://www.ama-assn.org/go/cpt Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use
  90697 http://www.ama-assn.org/go/cpt Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use
  90748 http://www.ama-assn.org/go/cpt Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use

Produced 08 Sep 2023